OMERS ADMINISTRATION Corp Cuts Stock Position in Danaher Corporation $DHR

OMERS ADMINISTRATION Corp lessened its position in Danaher Corporation (NYSE:DHR) by 5.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 82,167 shares of the conglomerate’s stock after selling 4,608 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Danaher were worth $18,810,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the 4th quarter worth $26,000. WFA of San Diego LLC acquired a new position in Danaher during the 2nd quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the 3rd quarter worth $27,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the 4th quarter worth $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Barclays lowered their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Jefferies Financial Group reissued a “buy” rating and set a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Robert W. Baird lowered their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Finally, Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $233.61.

Danaher Stock Up 0.5%

Shares of NYSE DHR opened at $181.04 on Tuesday. The company has a market capitalization of $128.13 billion, a price-to-earnings ratio of 35.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The business has a 50-day moving average of $180.73 and a two-hundred day moving average of $204.27. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 EPS. On average, analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.